Swedish Orphan Biovitrum (BIOVF)

Last Closing Price: --

Net Income (Quarterly)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Swedish Orphan Biovitrum (BIOVF) had Net Income of $140.54M for the most recently reported fiscal quarter, ending 2024-09-30.

Figures for fiscal quarter ending 2024-09-30
Income Statement Financials
$661.82M
Net Income
$140.54M
$127.78M
$534.05M
$466.08M
$195.74M
$-31.30M
$164.35M
$164.35M
$140.54M
$140.54M
$140.54M
$140.54M
$195.74M
$289.09M
343.01M
346.84M
$0.41
$0.41
Balance Sheet Financials
$1.21B
$36.86M
$5.72B
$6.93B
$1.33B
$1.10B
$2.03B
$3.37B
$3.56B
$-1.99B
$3.56B
343.44M
Cash Flow Statement Financials
$536.74M
$-287.04M
$-273.70M
$86.78M
$57.02M
$-29.76M
--
--
--
Fundamental Metrics & Ratios
0.91
--
--
0.24
0.31
80.69%
29.58%
29.58%
--
24.83%
21.24%
$529.54M
--
--
--
0.10
0.33
0.86
105.21
3.95%
-7.05%
2.03%
3.01%
$10.37
$1.53
$1.55